The Discounted Cash Flow (DCF) valuation of Biodesix, Inc. (BDSX) is (113.49) USD. With the latest stock price at 26.02 USD, the upside of Biodesix, Inc. based on DCF is -536.2%.
Based on the latest price of 26.02 USD and our DCF valuation, Biodesix, Inc. (BDSX) is a sell. selling Biodesix, stocks now will result in a potential gain of 536.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 9.5% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (854.35) - (63.27) | (113.49) |
| Upside | -3383.4% - -343.2% | -536.2% |